| Followers | 593 |
| Posts | 29864 |
| Boards Moderated | 0 |
| Alias Born | 01/30/2012 |
Thursday, January 05, 2023 1:00:35 PM
There’s a guy on StockTwits who says that the short interest is 41%.
He goes on to say that when the trade clears for his substantial shareholding he’ll be moving all his shares to his cash account. Apparently, anyone holding any shares in a cash account - those shares cannot be lent out to shorts by the broker.
He holds a substantial percentage of the minute float but has not stated exactly what percentage.
As we all know there’s a big gap at $6 which might even get filled today.
It’s been steadily churning higher and higher all afternoon. I can’t remember how many times it has tried to break the resistance at $5 but at the most it will break that resistance no later than the fourth attempt.
With some amazing price targets recently and the float steadily moving into the hands of longs or swing traders this could get very interesting.
This guy on StockTwits says that the really big moves like other recent biotech runners and the real fun with shorts will start on Monday!
He goes on to say that when the trade clears for his substantial shareholding he’ll be moving all his shares to his cash account. Apparently, anyone holding any shares in a cash account - those shares cannot be lent out to shorts by the broker.
He holds a substantial percentage of the minute float but has not stated exactly what percentage.
As we all know there’s a big gap at $6 which might even get filled today.
It’s been steadily churning higher and higher all afternoon. I can’t remember how many times it has tried to break the resistance at $5 but at the most it will break that resistance no later than the fourth attempt.
With some amazing price targets recently and the float steadily moving into the hands of longs or swing traders this could get very interesting.
This guy on StockTwits says that the really big moves like other recent biotech runners and the real fun with shorts will start on Monday!
My post are my opinion only. You should do your own due diligence before investing in any stock or take professional advice. I am not an investment advisor. Kind Regards.
Recent KPRX News
- Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway • Newsfile • 04/14/2026 11:00:00 AM
- Kiora Pharmaceuticals Announces Management Team Changes • Newsfile • 04/02/2026 08:30:00 PM
- Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials • Newsfile • 03/25/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:36:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 07:03:53 PM
- Kiora Pharmaceuticals to Present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference • Newsfile • 02/19/2026 01:30:00 PM
- Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds • Newsfile • 12/01/2025 11:45:00 AM
- Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases • Newsfile • 11/07/2025 11:00:00 AM
- Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders • PR Newswire (US) • 10/30/2025 01:00:00 PM
- Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025 • Newsfile • 10/15/2025 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/15/2025 08:15:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 11:14:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 11:01:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 06:34:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 11:00:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2025 11:02:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 10:59:55 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2025 02:00:09 PM
